Search

Your search keyword '"Schnur, Rhonda E."' showing total 284 results

Search Constraints

Start Over You searched for: Author "Schnur, Rhonda E." Remove constraint Author: "Schnur, Rhonda E."
284 results on '"Schnur, Rhonda E."'

Search Results

1. Elevated oxysterol and N‐palmitoyl‐O‐phosphocholineserine levels in congenital disorders of glycosylation

2. Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt

3. Biallelic variants in SLC4A10 encoding a sodium-dependent bicarbonate transporter lead to a neurodevelopmental disorder

4. De Novo Variants in RAB11B Cause Various Degrees of Global Developmental Delay and Intellectual Disability in Children

5. Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions

6. Widening of the genetic and clinical spectrum of Lamb–Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

7. Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size (vol 142, pg 2617, 2019)

8. Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size

9. New kinase‐deficient PAK2 variants associated with Knobloch syndrome type 2.

10. Biallelic loss-of-function variants in the splicing regulator NSRP1 cause a severe neurodevelopmental disorder with spastic cerebral palsy and epilepsy

11. UBA2 variants underlie a recognizable syndrome with variable aplasia cutis congenita and ectrodactyly

12. Biallelic and monoallelic variants in PLXNA1 are implicated in a novel neurodevelopmental disorder with variable cerebral and eye anomalies

13. Interference of nuclear mitochondrial DNA segments in mitochondrial DNA testing resembles biparental transmission of mitochondrial DNA in humans

14. CDK19-related disorder results from both loss-of-function and gain-of-function de novo missense variants

15. Mono and biallelic variants in HCN2 cause severe neurodevelopmental disorders

16. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia

17. Heterozygous variants that disturb the transcriptional repressor activity of FOXP4 cause a developmental disorder with speech/language delays and multiple congenital abnormalities

18. De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay

19. Defining the genotypic and phenotypic spectrum of X-linked MSL3-related disorder

20. De Novo Mutations of RERE Cause a Genetic Syndrome with Features that Overlap Those Associated with Proximal 1p36 Deletions

21. Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability

22. De novo variants of NR4A2 are associated with neurodevelopmental disorder and epilepsy

23. Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome

24. Variants in DOCK3 cause developmental delay and hypotonia

25. De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms

27. Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice

28. Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice

30. Fabry disease

31. List of Contributors

32. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

33. Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

34. Elevated Oxysterol andN‐ Palmitoyl‐ O ‐PhosphocholineserineLevels in Congenital Disorders of Glycosylation

35. Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities

36. De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease

37. Six new cases of CRB2‐related syndrome and a review of clinical findings in 28 reported patients

39. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language

40. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder

41. Heterozygous variants in PRPF8 are associated with neurodevelopmental disorders

43. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder

44. Six new cases of CRB2‐related syndrome and a review of clinical findings in 28 reported patients.

45. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss

46. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome

47. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44

48. Biallelic PRMT7pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities

49. De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder

50. Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy

Catalog

Books, media, physical & digital resources